What considerations guide the choice of opioid routes (oral, IV, subcutaneous) in palliative care?

Study for ELNEC 4: Symptom Management in Palliative Care Test with flashcards and multiple choice questions. Hints and explanations included! Get ready for your exam!

Multiple Choice

What considerations guide the choice of opioid routes (oral, IV, subcutaneous) in palliative care?

Selecting an opioid route in palliative care is about balancing how the drug is absorbed and acts with the patient’s current situation and goals. Oral opioids are convenient and appropriate when the patient can swallow and gut function is good, but their effectiveness can be variable due to absorption differences and first-pass metabolism, which means the onset is slower and the dose may need adjustment. If rapid relief or precise dosing is required, or if the patient cannot take anything by mouth, an IV route provides the fastest, most predictable onset with complete bioavailability, though it requires IV access and carries higher infection risk and monitoring needs. The subcutaneous route often sits between these two: it’s useful when oral administration isn’t feasible due to vomiting or poor absorption and is easier to manage than IV in many settings, especially in home or outpatient palliative care. It allows reliable titration and steady control with less invasive care than an IV line, but still carries a risk of injection-site infection or irritation. Organ function, particularly liver and kidney function, affects how opioids are metabolized and cleared, so the route may be chosen to avoid accumulation or toxicity. Practical factors like patient preference, how easily the route can be monitored, and the setting (home vs. hospital) also shape the decision. While cost and availability matter in real life, they are not the sole determinants, and the color of the medication or exclusive reliance on setting do not guide route choice.

Selecting an opioid route in palliative care is about balancing how the drug is absorbed and acts with the patient’s current situation and goals. Oral opioids are convenient and appropriate when the patient can swallow and gut function is good, but their effectiveness can be variable due to absorption differences and first-pass metabolism, which means the onset is slower and the dose may need adjustment. If rapid relief or precise dosing is required, or if the patient cannot take anything by mouth, an IV route provides the fastest, most predictable onset with complete bioavailability, though it requires IV access and carries higher infection risk and monitoring needs.

The subcutaneous route often sits between these two: it’s useful when oral administration isn’t feasible due to vomiting or poor absorption and is easier to manage than IV in many settings, especially in home or outpatient palliative care. It allows reliable titration and steady control with less invasive care than an IV line, but still carries a risk of injection-site infection or irritation. Organ function, particularly liver and kidney function, affects how opioids are metabolized and cleared, so the route may be chosen to avoid accumulation or toxicity. Practical factors like patient preference, how easily the route can be monitored, and the setting (home vs. hospital) also shape the decision. While cost and availability matter in real life, they are not the sole determinants, and the color of the medication or exclusive reliance on setting do not guide route choice.

More practice questions